NEW YORK,
March 29,
2023 /PRNewswire/ -- The Gross Law Firm issues the
following notice to shareholders of Amgen Inc..
Shareholders who purchased shares of AMGN during
the class period listed are encouraged to contact the firm
regarding possible lead plaintiff appointment. Appointment as lead
plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/amgen-inc-loss-submission-form/?id=37758&from=4
CLASS PERIOD: This lawsuit is on behalf of
all persons who purchased or otherwise acquired Amgen common stock
between July 29, 2020 and
April 27, 2022, inclusive.
ALLEGATIONS: The complaint alleges that
during the class period, Defendants issued materially false and/or
misleading statements and/or failed to disclose that: (a) the U.S.
government claimed Amgen owed more than $3
billion in back taxes for tax years 2010, 2011, and 2012;
(b) the U.S. government claimed Amgen owed more than $5 billion in back taxes for tax years 2013,
2014, and 2015; (c) the U.S. government would likely claim Amgen
owed materially more to the U.S. government than investors had been
led to believe for subsequent tax years for which the Company had
used the same profit allocation treatment between its U.S. and
Puerto Rico operations; (d) Amgen had not taken sufficient accruals
to account for its outstanding tax liabilities; (e) Amgen had
failed to comply with Accounting Standards Codification Topic 450
and other rules and regulations regarding the preparation of its
periodic filings with the U.S. Securities and Exchange Commission;
and (f) Amgen's refusal to pay taxes claimed by the U.S. government
exposed the Company to a substantial risk of severe financial
penalties imposed by the Internal Revenue Service.
DEADLINE: May 12,
2023 Shareholders should not delay in registering for
this class action. Register your information here:
https://securitiesclasslaw.com/securities/amgen-inc-loss-submission-form/?id=37758&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you
register as a shareholder who purchased shares of AMGN during the
timeframe listed above, you will be enrolled in a portfolio
monitoring software to provide you with status updates throughout
the lifecycle of the case. The deadline to seek to be a lead
plaintiff is May 12, 2023. There is
no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is
nationally recognized class action law firm, and our mission is to
protect the rights of all investors who have suffered as a result
of deceit, fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-amgen-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-may-12-2023--nasdaq-amgn-301784154.html
SOURCE The Gross Law Firm